Nitric Oxide: Clinical Trials

16 trials of Nitric Oxide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 terminated, 1 enrolling by invitation, 1 recruiting. 16 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 316Completed 11, Terminated 2, Enrolling by invitation 1, Recruiting 1, Unknown 1
Phase 25Completed 4, Enrolling by invitation 1

Follow Nitric Oxide: new trials by email Literature Review of Nitric Oxide trials Research Report on Nitric Oxide

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
NCX 470, Placebo - Open Angle Glaucoma
Phase 2 / Phase 3CompletedNicox Ophthalmics, Inc.182023-12-122025-09-08
NO During CPB in Neonates to Reduce Risk of AKI
Nitric Oxide, Oxygen - AKI, CHD - Congenital Heart Disease
Phase 3RecruitingChildren's Hospital Medical Center, Cincinnati402023-01-102026-08-05
Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass
Nitric Oxide (NO) 20 part per million (ppm), Standard of care cardiopulmonary bypass - Congenital Heart Disease, Congenital Heart Defect
Phase 2 / Phase 3Enrolling by invitationVanderbilt University Medical Center502022-04-252025-10-08
Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection
Nitric Oxide, Nasal spray with isotonic saline - SARS-CoV-2 Infection
Phase 3TerminatedSanotize Research and Development corp.13892021-11-202025-09-25
Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19
Nitric Oxide - SARS-CoV-2 Infection
Phase 3CompletedSanotize Research and Development corp.3062021-11-012022-10-31
Nitric Oxide During Cardiopulmonary Bypass in Adult Surgery
Nitric Oxide, standard of care treatment - Hypoxia
Phase 3UnknownRabin Medical Center3002021-08-142021-10-08
Nitric Oxide During Bypass for Arterial Switch Operation
Nitric Oxide - Low Cardiac Output Syndrome, Transposition of Great Vessels
Phase 3CompletedMurdoch Childrens Research Institute3002018-07-112024-04-18
Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation
Nitric Oxide, Placebo, INOmax - Inflammation, Platelet Dysfunction
Phase 2 / Phase 3CompletedMedical College of Wisconsin402018-04-252020-08-13
Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Nitric Oxide, Supportive treatment - Bronchiolitis
Phase 3CompletedBeyond Air Inc.692017-03-052019-07-09
Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.
Nitric Oxide, Placebo - Acute Kidney Injury
Phase 3CompletedMassachusetts General Hospital2502017-02-082026-03-10
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Nitric Oxide, respiratory support - Pulmonary Disease
Phase 2 / Phase 3CompletedFudan University4002011-05-012013-01-28
Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)
Nitric Oxide, Placebo - Sickle Cell Disease, Acute Chest Syndrome
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris1002008-12-012013-08-02
Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
Nitric oxide, Placebo - Lung Disease
Phase 3CompletedMallinckrodt8002005-05-292021-02-05
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
Nitric Oxide for inhalation, Oxygen, Nitric Oxide plus Oxygen - Idiopathic Pulmonary Arterial Hypertension, Cardiomyopathy
Phase 3CompletedMallinckrodt1362004-09-012019-12-20
Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation
nitric oxide for inhalation, Placebo - Ischemia-Reperfusion Injury
Phase 3TerminatedMallinckrodt842001-08-012016-09-09
Nitric Oxide Administration for Acute Respiratory Distress Syndrome
Nitric Oxide, No Intervention - Acute Respiratory Distress Syndrome
Phase 3CompletedChildren's Hospital of Philadelphia522000-09-012015-04-24

Conditions studied

Heart Defects, Congenital (4)  ·  Acute Lung Injury (2)  ·  COVID-19 (2)  ·  Lung Diseases (2)  ·  Acute Chest Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Anemia, Sickle Cell (1)  ·  Bronchiolitis (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Cardiac Output, Low (1)  ·  Cardiomyopathies (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Hypoxia (1)

Sponsors

Mallinckrodt (3)  ·  Sanotize Research and Development corp. (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Beyond Air Inc. (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Children's Hospital of Philadelphia (1)  ·  Fudan University (1)  ·  Massachusetts General Hospital (1)  ·  Medical College of Wisconsin (1)  ·  Murdoch Childrens Research Institute (1)  ·  Nicox Ophthalmics, Inc. (1)  ·  Rabin Medical Center (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (8)  ·  France (3)  ·  Canada (2)  ·  Israel (2)  ·  Netherlands (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  China (1)  ·  Finland (1)  ·  Germany (1)  ·  India (1)  ·  Indonesia (1)  ·  Italy (1)

Top investigators

Keith Moore, PHARMD (2)  ·  Bo Sun, Ph.D (1)  ·  David P Bichell, MD (1)  ·  Leonid Eidelman (1)  ·  Lorenzo Berra, MD (1)  ·  Neil MacIntyre, MD (1)  ·  Rodolfo I Godinez, MD, PhD (1)  ·  Warwick Butt (1)

Results publications

PMID 20405117, PMID 20655106, PMID 23228403, PMID 23940237, PMID 26431718, PMID 27686343, PMID 28046032, PMID 31278097, PMID 32541773, PMID 39037709, PMID 41270263

NIH funding

2004 (2), K23HL128882 (1)